Reuters Health Report

Click to View in Browser 01/23/2014 6.3 million eligible for Medicaid since Obamacare launch: U.S. agency NEW YORK (Reuters) - More than 6.3 million Americans were deemed eligible for government healthcare plans for the poor since the October 1 launch of President Barack Obama's healthcare law through December, federal officials reported on Wednesday. U.S. tobacco companies' appeal to delay court-ordered advertising blitz WASHINGTON (Reuters) - U.S. consumers will likely have to wait until 2015 or later to see a court-ordered advertising blitz detailing tobacco companies' deception, a lag of nine years after the original ruling, a court heard on Wednesday. Company in West Virginia spill failed to disclose second chemical The company behind a chemical spill that left about 300,000 people in West Virginia without tap water failed to disclose a second chemical in the leak, state officials said on Wednesday. High-fluoride paste may prevent white spots from braces NEW YORK (Reuters Health) - Adolescents may not be able to get out of wearing braces, but using a high-fluoride toothpaste for the duration could help them avoid white marks the devices often leave behind, according to a new study from Sweden. Stryker fourth-quarter profit up on higher sales, lower tax (Reuters) - U.S. orthopedic implant maker Stryker Corp said on Wednesday quarterly net profit rose 43 percent, driven by increased sales in its reconstructive and neurotechnology divisions as well as lower taxes. Scheduling changes, frequent breaks might reduce truck crashes NEW YORK (Reuters Health) - Long-distance truckers are almost three times more likely to get in an accident when they drive during midnight-to-dawn hours with few breaks, according to new research from Australia. Omega-3 intake linked to signs of brain aging NEW YORK (Reuters Health) - Older women with higher levels of omega-3 fatty acids in their blood had slightly less brain shrinkage than women with low fatty acid levels in a new study. FDA rejects wider use of Amag anemia drug; shares slide (Reuters) - Amag Pharmaceuticals Inc said the U.S. Food and Drug Administration rejected its application for wider use of its iron deficiency drug due to safety concerns and asked for more trial data, sending its shares down as much as 15 percent. U.S. Supreme Court tosses out Medtronic pacemaker patent loss WASHINGTON (Reuters) - The U.S. Supreme Court on Wednesday ruled in favor of medical devices maker Medtronic Inc in its dispute with privately owned Mirowski Family Ventures LLC over whether the larger company infringed on Mirowski's patents in making certain pacemakers. FDA rejects Amarin appeal on Vascepa trial design, shares slump (Reuters) - Amarin Corp Plc's shares fell more than 26 percent after U.S. health regulators rejected a preset testing process that was critical to the company seeking broader use of its blood fat-lowering drug. Related Video Entrepreneur cleans up in Gaza Stranded whales refloated in New Zealand The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend